Pancreatoblastoma (PB), or infantile pancreatic carcinoma, is an extremely rare pancreatic tumor in childhood, comprising 0.5% of pancreatic non-endocrine tumors. Although PB mainly presents during childhood but can also occur in adults. PB tend to be less aggressive in infants and children compared to adults. Children with PB usually present late with upper abdominal pain and many have a palpable mass in the epigastrium. Mechanical obstruction of the upper duodenum and gastric outlet by tumor in the head of the pancreas may be associated with vomiting, jaundice and gastrointestinal bleeding. Histologically, PB is characterized with distinct acinar and squamoid cell differentiation. PB has been associated with alterations in the Wnt signaling pathway and chromosome 11p loss of heterozygosity (LOH), Beckwith-Wiedemann syndrome and familial adenomatous polyposis. The majority of these tumors arise in the head of the pancreas. Alpha-fetoprotein may be elevated in up to 68% of patients with PB. Ultrasound and CT scan may be useful but preoperative diagnosis is often quite difficult. The treatment of choice is complete resection, that may often be curative. The role of adjuvant chemotherapy or radiotherapy is still under discussion due to small number of patients treated as yet. Chemotherapy regimens consisting of cyclophosphamide, etoposide, doxorubicin, and cisplatin have been used in neoadjuvant setting with anecdotal benefit. Prognosis of this rare tumor is good, when resected completely. Prognosis is poorer, when there is metastasis or when it is inoperable. On the whole, PB is regarded to be a curable tumor; hence the clinical diagnosis should be made early. Awareness of this rare tumor of pancreas is essential for early detection and proper management. The author review the clinical presentation, etiology, diagnosis, treatment and prognosis of PB in this presentation.
Available from: europepmc.org
- "Prognosis is dismal when there is metastasis or when it is
inoperable(5). The benefit of
adjuvant chemotherapy has not been fully elucidated but it is commonly used for
unresectable tumors at diagnosis and metastatic disease(2-4). Radiotherapy
is usually recommended for patients with unresectable tumors or after incomplete
surgical resection(6,7). High dose chemotherapy with regimens such as melphalan,
carboplatin and etoposide combined with autologous hematopoietic stem cell
transplantation (ASTC) has been suggested as an alternative for patients with lesions
not completely resected but its role is not yet fully defined(7,8). "
[Show abstract] [Hide abstract]
ABSTRACT: Pancreatoblastoma is a rare tumor and surgery with complete resection is the main
treatment approach. Prognosis for patients with residual disease after surgery is
usually dismal. A 14-year-old girl with pancreatoblastoma in the pancreatic body and
tail was submitted to preoperative chemotherapy. She underwent surgery and the tumor
was resected with microscopic margins. Postoperative chemotherapy was followed by
high dose chemotherapy and autologous hematopoietic stem cell transplantation. After
four years she remains very well with no evidence of disease. This is the first case
reported of pancreatoblastoma that was treated with autologous hematopoietic stem
cell transplantation as first line treatment without radiotherapy at the site of the
Revista Brasileira de Hematologia e Hemoterapia 04/2013; 35(2):148-9. DOI:10.5581/1516-8484.20130038
Available from: PubMed Central
- "Pancreatoblastoma usually affects children between 1-8 yr, although rare cases in adults have been reported (2). There is a male predominance and more than half of the reported cases are in Asians (3, 4). The tumor may arise from any portion of the pancreas; however, a tumor that originates from ectopic pancreatic tissue is extremely rare. "
[Show abstract] [Hide abstract]
ABSTRACT: Pancreatoblastoma is a rare primary pancreatic neoplasm of children that may arise in any portion of the pancreas. We report a case of a 3-yr-old boy who presented to with abdominal pain our hospital and a progressive bulge in his right abdomen. Biochemical evaluation and serum levels of tumoral markers were within reference limits. On the computed tomography, two tumors were found. One located in the head of the pancreas; however, a laparotomy revealed that the head of pancreas was compressed but normal. The other was in the left abdomen near the spleen and the tail of the pancreas. The diagnosis of two synchronous pancreatoblastoma originating from the omentum was confirmed by pathology. Therefore, a pancreatoblastoma should be considered when a large well-defined, lobulated, and heterogeneous mass is identified in the pancreas of children. In addition, an ectopic pancreatoblastoma should be considered when identified within or near the ectopic pancreatic tissue.
Journal of Korean medical science 06/2011; 26(6):832-5. DOI:10.3346/jkms.2011.26.6.832 · 1.27 Impact Factor
Pancreas 05/2008; 36(3):320-2. DOI:10.1097/MPA.0b013e31815842c0 · 2.96 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.